This statement sets out the conclusions of the Joint Committee on Vaccination and Immunisation (JCVI) on extending the HPV vaccination programme to adolescent boys in the UK. "If considering a cost-effectiveness analysis where a combined girls’ and boys’ programme is compared to no vaccination, gender-neutral HPV vaccination is highly likely to be cost-effective"